Welcome, Guest. Please login or register.
October 14, 2024, 08:39:43 am

Login with username, password and session length


Members
Stats
  • Total Posts: 55133
  • Total Topics: 4851
  • Online Today: 233
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 0
Guests: 164
Total: 164

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Hep C Treatment Tied to Lower Risk of Liver Cancer and Death From Any Cause  (Read 8776 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) is associated with lower risks of hepatocellular carcinoma (HCC, the most common form of liver cancer) and death from any cause, Infectious Disease Advisor reports.

Publishing their findings in The Lancet, researchers screened 10,166 people with hep C in 32 French hepatology centers between August 2012 and December 2015. The study excluded those with hepatitis B virus, a history of decompensated cirrhosis (the more advanced form of the severe liver disease), a history of liver cancer, a history of liver transplantation and those previously treated with interferon and ribavirin.

Read more...
https://www.hepmag.com/article/hep-c-treatment-tied-lower-risk-liver-cancer-death-cause

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.